UC Santa Barbara researchers, in collaboration with the biotech firm, Endocyte, have put a new twist on a common drug, which could successfully treat PKD in the future. In earlier research, UCSB scientist Thomas Weimbs had identified the immunosuppressant drug rapamycin as a good candidate for PKD treatment. While rapamycin effectively stopped PKD progression in … Continue reading New Version of the Drug Rapamycin May Be Future PKD Treatment
Skip to content
UKRO – University Kidney Research Organization
Together We Build a Kidney